Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Discovery pharmaceutics--challenges and opportunities.

Xue-Qing Chen1, Melissa D Antman, Christoph Gesenberg

  • 1Discovery Pharmaceutics, Preclinical Candidate Optimization, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.

The AAPS Journal
|June 27, 2006
PubMed
Summary

Early drug discovery requires evaluating physicochemical properties like solubility and lipophilicity. This helps identify development challenges and select optimal drug candidates, reducing costs and timelines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Chemical Components and Pharmacological Activities of Different Processing Methods in Magnolia denudata Desr. 'Hailuo' Using GC-MS and Network Pharmacology.

Combinatorial chemistry & high throughput screening·2026
Same author

From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective <i>N</i>-Formyl Peptide Receptor 2 Agonist.

Journal of medicinal chemistry·2026
Same author

Utilizing Flux to Inform Formulation Strategy Decisions in Preclinical Studies.

Molecular pharmaceutics·2026
Same author

Four new phenylpropanoid glucosides from <i>Artemisia annua</i> L.

Natural product research·2025
Same author

Hydrolysis of cellulose acetate phthalate and hydroxypropyl methylcellulose phthalate in amorphous solid dispersions.

Journal of pharmaceutical sciences·2024
Same author

Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.

Pharmaceutical research·2023

Area of Science:

  • Drug Discovery and Development
  • Pharmaceutical Sciences
  • Medicinal Chemistry

Background:

  • Pharmaceutical companies increasingly evaluate druglike properties early in discovery.
  • Lead nomination often relies on pharmacology and toxicology, overlooking biopharmaceutical properties.
  • Suboptimal physicochemical parameters lead to poor biopharmaceutical properties, increasing development costs and timelines.

Purpose of the Study:

  • To highlight the importance of early evaluation of physicochemical parameters in drug discovery.
  • To identify key parameters and approaches for assessing compounds in early development.
  • To optimize preformulation strategies for better pharmacokinetic and toxicological profiling.

Main Methods:

  • Review of physicochemical parameters relevant to biopharmaceutical properties (solubility, lipophilicity, stability).

Related Experiment Videos

  • Discussion of preformulation approaches for early-stage compound evaluation.
  • Summary of methods for assessing pharmacokinetic and toxicological properties.

    • Main Results:

    • Early assessment of physicochemical properties aids in identifying potential development challenges.
    • Optimized preformulation and early evaluation of parameters improve candidate selection.
    • Integrating biopharmaceutical assessments early can mitigate risks associated with poor drug properties.

    Conclusions:

    • Evaluating physicochemical parameters early is crucial for successful drug development.
    • Optimized preformulation and early biopharmaceutical profiling enhance candidate selection.
    • Proactive assessment of these properties reduces development timelines and costs.